| 参考文献 [1] Masakazu H, Noriyuki T, Bonnee R, et al. Molecular cloning of a novel mitogen-inducible nuclear protein with a Ran GTPase-activating domain that affects cell cycle progression. Molecular and Cellular Biology, Jan. 1995;5(4): 552-560. [2] Kometani K, Aoki M, Kawamata S et al. Role of SPA-1 in phenotypes of CML induced by BCR-ABL-expressing hematopoietic progentiors in mouse model. Cancer Res 2006; 66(5): 9967-9976. [3] Ishida D, Kometani K, Hailin Y, et a1．Myeloproliferative stem cell disorders by deregulated Rap1 activation in SPA-1-deficient mice．Cancer Cell, 2003, 4(1): 55-65． [4] Hattori M, Minato N. Rap1GTPase: Functions, Regulation and Malignancy． J Biochem (Tokyo), 2003, 134(4): 479-484． [5] Ohba Y, Kurokawa K, Matsuda M. Mechanism of the spatiotemporal regulation of Ras and Rap. EMBO J, 2003, 22(4): 859-869. [6] Su I, Hattori M, Moriyama M, et a1. AF-6 controls integrin-mediated cell adhesion by regulating Rapl activation through the specific recruitment of RaplGTP and Spa-1. J Biol Chem, 2003, 278(17): l5232-l5238. [7] Park YG, Zhao X, Lesueur F et al. Sipa1 is a candidate for underlying the metastasis efficiency modifier locus. Mtes1 Nat Genet 2005; 37(2): 1055-1062. [8] Wada Y, Kubota H, Maeda M et al. Mitogen-inducible SIPA1 is mapped to the conserved syntenic groups of chromosome 19 in mouse and chromosome 11q13.3 centromeric to BCL1 in human. Genomics 1997; 3(9): 66-73. [9] Crawford NP, Walker RC, Lukes L, et al. The Diasporin Pathway: tumor progression-related transcriptional network that predicts breast cancer survival. Clin Exp Metastasis. 2008; 25(7):357-369. |
